After the government imposed a ban on widely used anti-diabetes drug pioglitazone, city patients and diabetologists are in the dock.
The drug, which is quite popular with Type 2 diabetes patients, is consumed by about 10% of city’s population, claimed city diabetologist Dr Abhay Mutha at a press conference on Friday.
Chief diabetologist at Ruby hall Clinic, Mutha said, “The ban of pioglitazone came as a rude shock to us. It is one of the most prescribed medicines to our patients suffering from Type 2 diabetes. The medicine, being cheap and highly effective with minimum side effects is also used widely in western countries.”
Mutha said that the reasoning for the ban wasn’t clear and that government officials should consult the medical practitioners and reconsider the decision.
Diabetologist Dr Shrirang Godbole said that with the ban, the only available option that doctors have for the patients is to prescribe alternative medication or initiate the use of insulin. “I have been receiving frantic calls from my patients regarding the same,” he said.
There are other drugs available in the market with varying pioglitazone combination, but they are less effective, said Mutha.